Eagle Pharmaceuticals Inc
General ticker "EGRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.9M
Eagle Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -32.9%.
Estimated limits based on current volatility of 26.0%: low 0.34$, high 0.59$
Factors to consider:
- Current price 97.7% below estimated low
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [24.99$, 41.60$]
- 2023-12-31 to 2024-12-30 estimated range: [25.52$, 42.58$]
Financial Metrics affecting the EGRX estimates:
- Positive: Non-GAAP EPS, $ of 7.82 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Positive: Operating profit margin, % of 25.57 > 19.51
- Positive: Interest expense per share, $ of 0.31 <= 0.74
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term EGRX quotes
Long-term EGRX plot with estimates
Financial data
YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|
Operating Revenue | $187.80MM | $171.55MM | $316.61MM |
Operating Expenses | $154.85MM | $168.78MM | $235.65MM |
Operating Income | $32.95MM | $2.77MM | $80.96MM |
Non-Operating Income | $-10.28MM | $-7.32MM | $-19.53MM |
Interest Expense | $2.58MM | $1.64MM | $4.04MM |
R&D Expense | $30.79MM | $51.27MM | $34.09MM |
Income(Loss) | $22.68MM | $-4.55MM | $61.43MM |
Taxes | $10.69MM | $4.08MM | $25.79MM |
Profit(Loss) | $11.99MM | $-8.63MM | $35.64MM |
Stockholders Equity | $186.01MM | $176.45MM | $233.56MM |
Inventory | $8.07MM | $21.91MM | $47.79MM |
Assets | $253.19MM | $253.73MM | $406.16MM |
Operating Cash Flow | $49.50MM | $28.22MM | $50.70MM |
Capital expenditure | $0.75MM | $0.32MM | $0.18MM |
Investing Cash Flow | $-18.25MM | $-5.32MM | $-86.83MM |
Financing Cash Flow | $-37.87MM | $-28.39MM | $-6.21MM |
Earnings Per Share* | $0.89 | $-0.66 | $2.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.